Therapeutic Apheresis A US Market Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Drug Discovery and Development Industry: Celldex Therapeutics, Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development Industry: Celldex Therapeutics, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 82 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Celldex Therapeutics, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

Industries: Therapy | Countries: United States

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 104 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CSL Limited's corporate website, SEC filings, investo ...

Industries: Therapy | Countries: United States, World

Drug Discovery and Development in Russian Federation: CEL-SCI Corporation - Product Pipeline Review - H2 2011

Drug Discovery and Development in Russian Federation: CEL-SCI Corporation - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 82 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CEL-SCI Corporation's corporate website, SEC filings, ...

Industries: Therapy | Countries: World, United States

Pharmaceutical in United States: Hospira, Inc. ? Product Pipeline Review - H2 2011

Pharmaceutical in United States: Hospira, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 111 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Hospira, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information ...

Industries: Therapy | Countries: United States, World, Australia

Pathology in United States: LEO Pharma A/S - Product Pipeline Review - H2 2011

Pathology in United States: LEO Pharma A/S - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 100 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, LEO Pharma A/S's corporate website, SEC filings, ...

Industries: Therapy | Countries: United States, World

Drug Discovery and Development in United States: Kuros Biosurgery AG - Product Pipeline Review - H2 2011

Drug Discovery and Development in United States: Kuros Biosurgery AG - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 44 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Kuros Biosurgery AG's corporate website, SEC filings, ...

Industries: Therapy | Countries: United States, World

Drug and Medication in Philippines: Lupin Limited - Product Pipeline Review - H2 2011

Drug and Medication in Philippines: Lupin Limited - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 79 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Lupin Limited's corporate website, SEC filings, investo ...

Industries: Therapy | Countries: Philippines, World, India, United States

Pharmaceutical in United States: Sigma-Tau S.p.A. ? Product Pipeline Review - H2 2011

Pharmaceutical in United States: Sigma-Tau S.p.A. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 99 pages

.A. - Product Pipeline Review - H2 2011? provides a detailed overview on the Sigma-Tau S.p.A.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data ...

Industries: Therapy | Countries: Italy, United States

Elekta AB (Symbol:EKTA B) SWOT Analysis, Strategy, Revenues and Profits

Elekta AB (Symbol:EKTA B) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • May 2012
  • 51 pages

Elekta AB (Elekta) is a medical technology company engaged in the development of advanced clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. It principally operates under three divisions, namely, Elekta Neuroscience, which ...

Industries: Therapy | Countries: United States

Healthpoint Biotherapeutics - Strategic SWOT Analysis Review

Healthpoint Biotherapeutics - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • May 2012
  • 42 pages

Healthpoint Biotherapeutics - Strategic SWOT Analysis Review Summary Healthpoint Biotherapeutics (Healthpoint) is a bio-biopharmaceutical company that develops and markets pharmaceutical, biologic and medical devices used for tissue repair and healing. The company offers products for the prevention and ...

Industries: Therapy | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 618 48 97

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.